Modeling solution
From Atom to living organisms
InSiliBio, molecular modeling for your R&D.. |
|||||||||||||||||||
InSiliBio is a wonderful toolbox of innovative digital techniques for performing molecular modeling simulations. We support the R&D of our partners and customers by understanding mechanisms of action related to biological activities, and by highlighting key processes at the molecular level. InSiliBio gathers experts in molecular modeling Reliable methods and methodologies are employed to study:
|
|||||||||||||||||||
|
|||||||||||||||||||
Drug carriers |
|||||||||||||||||||
Drug carriers are a matter of intense development in pharmaceutical formulation. They allow better control of drug stability, delivery and bioavailability. They are key to improving treatment efficacy and acceptance, especially through better control of dosage. By using quantum chemistry calculations and molecular dynamic simulations, InSiliBio simulates the conformational and dynamic behavior of peptides, liposomes, nanoparticles and various other drug carriers. The drug delivery process can also be rationalized by studying the interactions between biological membrane models and the drug carriers. The mechanism of drug release can also be elucidated at this stage. The structure-property relationships that can be established provide chemical recommendations to improve drug transport and delivery. |
|||||||||||||||||||
Intermolecular interactions |
|||||||||||||||||||
Non-covalent intermolecular interactions between drugs or between drugs and other (endogenous / exogenous) compounds can drive biological actions, in particular synergistic or antagonistic effects. Such interactions can occur in different compartments, more or less hydrophilic. Quantum chemistry calculations and molecular dynamic simulations provide highly accurate descriptions of physical-chemical properties of drugs and help to gain insight into such intermolecular interactions. The driving forces of these interactions are often crucial to rationalize biological properties. | |||||||||||||||||||
Protein-ligand interactions |
|||||||||||||||||||
Protein-ligand interaction is a key step in drug activity and pharmacodynamics. In silico methods have become highly efficient to study various aspects of protein activity, ligand-protein interactions, protein polymorphisms, and large conformational changes. Molecular simulations performed at InSiliBio, followed by in-depth analyses, help to comprehensively explore these different aspects at atomic resolution. In addition, in silico simulations shed light on the complex conformational changes that occur during protein binding / unbinding. This supports the development of more effective drugs and therapies that target specific proteins and related functions. |
... from questions to conclusionsProblematicWe start by meeting with our experts in physical-chemistry and molecular modeling to discuss your problem. Together, we propose solutions to unravel the molecular interactions that give rise to the biological action of your active compounds. |
Conceptualization
|
3D modeling & parameterization
|
Our computing power at your serviceThe calculations are achieved on our supercomputers. The simulation time depends on the size of the molecular system and the time-scale of the chemical and biological processes under investigation. The behavior of the molecular assemblies is monitored daily, to optimize the simulation time and further data mining. |
Scientific & commercial deliveriesA thorough analysis of the data (sampling of numerous molecular events) unravels your scientific problem and InSiliBio delivers:
|
|